These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23990516)

  • 1. Residual β-Cell function 3-6 years after onset of type 1 diabetes reduces risk of severe hypoglycemia in children and adolescents.
    Sørensen JS; Johannesen J; Pociot F; Kristensen K; Thomsen J; Hertel NT; Kjaersgaard P; Brorsson C; Birkebaek NH;
    Diabetes Care; 2013 Nov; 36(11):3454-9. PubMed ID: 23990516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of near physiologic insulin therapy on hypoglycemia counterregulation in type-1 diabetes.
    Bischof MG; Bernroider E; Ludwig C; Kurzemann S; Kletter K; Waldhäusl W; Roden M
    Horm Res; 2001; 56(5-6):151-8. PubMed ID: 11910200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual β-cell function and the insulin-like growth factor system in Danish children and adolescents with type 1 diabetes.
    Sorensen JS; Birkebaek NH; Bjerre M; Pociot F; Kristensen K; Hoejberg AS; Frystyk J;
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1053-61. PubMed ID: 25532040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of diabetic ketoacidosis, severe hypoglycemia and glycemic control among children and young adults with type 1 diabetes mellitus treated with premixed versus basal-bolus insulin therapy.
    Chou WY; Li YR; Chan WK; Chen ST
    Biomed J; 2018 Dec; 41(6):348-355. PubMed ID: 30709576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
    Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
    Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized Trial.
    Tauschmann M; Allen JM; Nagl K; Fritsch M; Yong J; Metcalfe E; Schaeffer D; Fichelle M; Schierloh U; Thiele AG; Abt D; Kojzar H; Mader JK; Slegtenhorst S; Barber N; Wilinska ME; Boughton C; Musolino G; Sibayan J; Cohen N; Kollman C; Hofer SE; Fröhlich-Reiterer E; Kapellen TM; Acerini CL; de Beaufort C; Campbell F; Rami-Merhar B; Hovorka R;
    Diabetes Care; 2019 Apr; 42(4):594-600. PubMed ID: 30692242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose.
    Hao W; Gitelman S; DiMeglio LA; Boulware D; Greenbaum CJ;
    Diabetes Care; 2016 Oct; 39(10):1664-70. PubMed ID: 27422577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in glycemic control through changes in insulin regimens: findings from a Japanese cohort of children and adolescents with type 1 diabetes.
    Mochizuki M; Kikuchi T; Urakami T; Kikuchi N; Kawamura T; Yokomichi H; Hoshino T; Matsuura N; Sasaki N; Sugihara S; Amemiya S;
    Pediatr Diabetes; 2017 Sep; 18(6):435-442. PubMed ID: 27460670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function.
    Kielgast U; Krarup T; Holst JJ; Madsbad S
    Diabetes Care; 2011 Jul; 34(7):1463-8. PubMed ID: 21593296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.
    Ahmed AB; Home PD
    Diabetes Care; 1998 Jan; 21(1):32-7. PubMed ID: 9538967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Safety and Glycemic Control During Football Tournament in Children and Adolescents With Type 1 Diabetes-Results of GoalDiab Study.
    Gawrecki A; Araszkiewicz A; Szadkowska A; Biegański G; Konarski J; Domaszewska K; Michalak A; Skowrońska B; Adamska A; Naskręt D; Jarosz-Chobot P; Szypowska A; Klupa T; Zozulińska-Ziółkiewicz D
    Pediatr Exerc Sci; 2019 Nov; 31(4):401-407. PubMed ID: 30955442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial comparing the rate of hypoglycemia--assessed using continuous glucose monitoring--in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study).
    Danne T; Philotheou A; Goldman D; Guo X; Ping L; Cali A; Johnston P
    Pediatr Diabetes; 2013 Dec; 14(8):593-601. PubMed ID: 23730996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations and beta cell function in Swedish diabetic children have remained unchanged during the last 25 years.
    Nordwall M; Ludvigsson J
    Diabetes Metab Res Rev; 2008 Sep; 24(6):472-9. PubMed ID: 18613248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes.
    Korzon-Burakowska A; Hopkins D; Matyka K; Lomas J; Pernet A; Macdonald I; Amiel S
    Diabetes Care; 1998 Feb; 21(2):283-90. PubMed ID: 9539997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and predictors of severe hypoglycemia in Danish children and adolescents with diabetes.
    Johansen A; Kanijo B; Fredheim S; Olsen B; Hertz B; Lauridsen MH; Andersen ML; Mortensen HB; Svensson J;
    Pediatr Diabetes; 2015 Aug; 16(5):354-60. PubMed ID: 25039921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual β cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia.
    Gubitosi-Klug RA; Braffett BH; Hitt S; Arends V; Uschner D; Jones K; Diminick L; Karger AB; Paterson AD; Roshandel D; Marcovina S; Lachin JM; Steffes M; Palmer JP;
    J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33529168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Young children with type 1 diabetes can achieve glycemic targets without hypoglycemia: Results of a novel intensive diabetes management program.
    Phelan H; King B; Anderson D; Crock P; Lopez P; Smart C
    Pediatr Diabetes; 2018 Jun; 19(4):769-775. PubMed ID: 29504243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POSTPRANDIAL DOSING OF BOLUS INSULIN IN PATIENTS WITH TYPE 1 DIABETES: A CROSS-SECTIONAL STUDY USING DATA FROM THE T1D EXCHANGE REGISTRY.
    Peters A; Van Name MA; Thorsted BL; Piltoft JS; Tamborlane WV
    Endocr Pract; 2017 Oct; 23(10):1201-1209. PubMed ID: 28704103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.